-
1
-
-
0032721931
-
The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease
-
Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, et al. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Mov Disord 1999; 14: 9406.
-
(1999)
Mov Disord
, vol.14
, pp. 9406
-
-
Ahlskog, J.E.1
Uitti, R.J.2
O'Connor, M.K.3
Maraganore, D.M.4
Matsumoto, J.Y.5
Stark, K.F.6
-
2
-
-
15544391275
-
Parkinson's disease: In vivo assessment of disease progression using positron emission tomography
-
Au WL, Adams JR, Troiano AR, Stoessl AJ. Parkinson's disease: in vivo assessment of disease progression using positron emission tomography. Brain Res Mol Brain Res 2005; 134: 2433.
-
(2005)
Brain Res Mol Brain Res
, vol.134
, pp. 2433
-
-
Au, W.L.1
Adams, J.R.2
Troiano, A.R.3
Stoessl, A.J.4
-
3
-
-
0029125857
-
Aging, energy, and oxidative stress in neurodegenerative diseases
-
Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995; 38: 35766.
-
(1995)
Ann Neurol
, vol.38
, pp. 35766
-
-
Beal, M.F.1
-
4
-
-
33646375711
-
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
-
Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006; 38: 51517.
-
(2006)
Nat Genet
, vol.38
, pp. 51517
-
-
Bender, A.1
Krishnan, K.J.2
Morris, C.M.3
Taylor, G.A.4
Reeve, A.K.5
Perry, R.H.6
-
5
-
-
58149373934
-
Relationship of Striatal Dopamine Synthesis Capacity to Age and Cognition
-
Braskie MN, Wilcox CE, Landau SM, O'Neil JP, Baker SL, Madison CM, et al. Relationship of Striatal Dopamine Synthesis Capacity to Age and Cognition. J Neurosci 2008; 28: 143208.
-
(2008)
J Neurosci
, vol.28
, pp. 143208
-
-
Braskie, M.N.1
Wilcox, C.E.2
Landau, S.M.3
O'Neil, J.P.4
Baker, S.L.5
Madison, C.M.6
-
6
-
-
0242302336
-
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease
-
Brooks DJ, Frey KA, Marek KL, Oakes D, Paty D, Prentice R, et al. Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease. Exp Neurol 2003; 184 (Suppl 1): S6879.
-
(2003)
Exp Neurol
, vol.184
, Issue.SUPPL 1
-
-
Brooks, D.J.1
Frey, K.A.2
Marek, K.L.3
Oakes, D.4
Paty, D.5
Prentice, R.6
-
7
-
-
0025065388
-
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
-
Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol 1990; 28: 54755.
-
(1990)
Ann Neurol
, vol.28
, pp. 54755
-
-
Brooks, D.J.1
Ibanez, V.2
Sawle, G.V.3
Quinn, N.4
Lees, A.J.5
Mathias, C.J.6
-
8
-
-
0033800917
-
Parkinson's disease is not one disease
-
Calne DB. Parkinson's disease is not one disease. Parkinsonism Relat Disord 2000; 7: 37.
-
(2000)
Parkinsonism Relat Disord
, vol.7
, pp. 37
-
-
Calne, D.B.1
-
9
-
-
0021089452
-
Aetiology of Parkinson's disease
-
Calne DB, Langston JW. Aetiology of Parkinson's disease. Lancet 1983; 2: 14579.
-
(1983)
Lancet
, vol.2
, pp. 14579
-
-
Calne, D.B.1
Langston, J.W.2
-
10
-
-
0023884372
-
Late progression of post-encephalitic Parkinson's syndrome
-
Calne DB, Lees AJ. Late progression of post-encephalitic Parkinson's syndrome. Can J Neurol Sci 1988; 15: 1358.
-
(1988)
Can J Neurol Sci
, vol.15
, pp. 1358
-
-
Calne, D.B.1
Lees, A.J.2
-
11
-
-
0026695663
-
Criteria for diagnosing Parkinson's disease
-
Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992; 32 (Suppl): S1257.
-
(1992)
Ann Neurol
, vol.32
, Issue.SUPPL
-
-
Calne, D.B.1
Snow, B.J.2
Lee, C.3
-
12
-
-
0242363670
-
Molecular pathways of neurodegeneration in Parkinson's disease
-
Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003; 302: 81922.
-
(2003)
Science
, vol.302
, pp. 81922
-
-
Dawson, T.M.1
Dawson, V.L.2
-
13
-
-
0025954066
-
Ageing and Parkinson's disease: Substantia nigra regional selectivity
-
Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114 (Pt 5): 2283301.
-
(1991)
Brain
, vol.114
, pp. 2283301
-
-
Fearnley, J.M.1
Lees, A.J.2
-
14
-
-
0023203420
-
A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum
-
Garnett ES, Lang AE, Chirakal R, Firnau G, Nahmias C. A rostrocaudal gradient for aromatic acid decarboxylase in the human striatum. Can J Neurol Sci 1987; 14: 4447.
-
(1987)
Can J Neurol Sci
, vol.14
, pp. 4447
-
-
Garnett, E.S.1
Lang, A.E.2
Chirakal, R.3
Firnau, G.4
Nahmias, C.5
-
15
-
-
0035849532
-
Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD
-
Guttman M, Stewart D, Hussey D, Wilson A, Houle S, Kish S. Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology 2001; 56: 155964.
-
(2001)
Neurology
, vol.56
, pp. 155964
-
-
Guttman, M.1
Stewart, D.2
Hussey, D.3
Wilson, A.4
Houle, S.5
Kish, S.6
-
16
-
-
14944354884
-
Sydney Multicenter Study of Parkinson's disease: Non-L-dopa-responsive problems dominate at 15 years
-
Hely MA, Morris JG, Reid WG, Trafficante R. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005; 20: 1909.
-
(2005)
Mov Disord
, vol.20
, pp. 1909
-
-
Hely, M.A.1
Morris, J.G.2
Reid, W.G.3
Trafficante, R.4
-
17
-
-
14844300111
-
Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity
-
Hilker R, Schweitzer K, Coburger S, Ghaemi M, Weisenbach S, Jacobs AH, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol 2005; 62: 37882.
-
(2005)
Arch Neurol
, vol.62
, pp. 37882
-
-
Hilker, R.1
Schweitzer, K.2
Coburger, S.3
Ghaemi, M.4
Weisenbach, S.5
Jacobs, A.H.6
-
18
-
-
34447636064
-
Changes in network activity with the progression of Parkinson's disease
-
Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007; 130: 183446.
-
(2007)
Brain
, vol.130
, pp. 183446
-
-
Huang, C.1
Tang, C.2
Feigin, A.3
Lesser, M.4
Ma, Y.5
Pourfar, M.6
-
19
-
-
0026635461
-
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease
-
The Royal Kings and Queens Parkinson's Disease Research Group
-
Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 1992; 32 (Suppl): S827.
-
(1992)
Ann Neurol
, vol.32
, Issue.SUPPL.
-
-
Jenner, P.1
Dexter, D.T.2
Sian, J.3
Schapira, A.H.4
Marsden, C.D.5
-
20
-
-
43249114934
-
Lewy bodylike pathology in long-term embryonic nigral transplants in Parkinson's disease
-
Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy bodylike pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008; 14: 5046.
-
(2008)
Nat Med
, vol.14
, pp. 5046
-
-
Kordower, J.H.1
Chu, Y.2
Hauser, R.A.3
Freeman, T.B.4
Olanow, C.W.5
-
21
-
-
33646351299
-
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons
-
Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 2006; 38: 51820.
-
(2006)
Nat Genet
, vol.38
, pp. 51820
-
-
Kraytsberg, Y.1
Kudryavtseva, E.2
McKee, A.C.3
Geula, C.4
Kowall, N.W.5
Khrapko, K.6
-
22
-
-
0032829070
-
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
-
Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 1999; 46: 598605.
-
(1999)
Ann Neurol
, vol.46
, pp. 598605
-
-
Langston, J.W.1
Forno, L.S.2
Tetrud, J.3
Reeves, A.G.4
Kaplan, J.A.5
Karluk, D.6
-
23
-
-
18844471416
-
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease
-
Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 2000; 47: 493503.
-
(2000)
Ann Neurol
, vol.47
, pp. 493503
-
-
Lee, C.S.1
Samii, A.2
Sossi, V.3
Ruth, T.J.4
Schulzer, M.5
Holden, J.E.6
-
24
-
-
10044247418
-
Lack of regional selectivity during the progression of Parkinson disease: Implications for pathogenesis
-
Lee CS, Schulzer M, de la Fuente-Fernandez R, Mak E, Kuramoto L, Sossi V, et al. Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Arch Neurol 2004; 61: 19205.
-
(2004)
Arch Neurol
, vol.61
, pp. 19205
-
-
Lee, C.S.1
Schulzer, M.2
De La Fuente-Fernandez, R.3
Mak, E.4
Kuramoto, L.5
Sossi, V.6
-
25
-
-
0028236839
-
Clinical observations on the rate of progression of idiopathic parkinsonism
-
Lee CS, Schulzer M, Mak EK, Snow BJ, Tsui JK, Calne S, et al. Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 1994; 117 (Pt 3): 5017.
-
(1994)
Brain
, vol.117
, Issue.PART 3
, pp. 5017
-
-
Lee, C.S.1
Schulzer, M.2
Mak, E.K.3
Snow, B.J.4
Tsui, J.K.5
Calne, S.6
-
26
-
-
34548646396
-
The relationship of Parkinson disease with aging
-
Levy G. The relationship of Parkinson disease with aging. Arch Neurol 2007; 64: 12426.
-
(2007)
Arch Neurol
, vol.64
, pp. 12426
-
-
Levy, G.1
-
27
-
-
14544303625
-
Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach
-
Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 2005; 76: 3438.
-
(2005)
J Neurol Neurosurg Psychiatry
, vol.76
, pp. 3438
-
-
Lewis, S.J.1
Foltynie, T.2
Blackwell, A.D.3
Robbins, T.W.4
Owen, A.M.5
Barker, R.A.6
-
28
-
-
43249110200
-
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
-
Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008; 14: 5013.
-
(2008)
Nat Med
, vol.14
, pp. 5013
-
-
Li, J.Y.1
Englund, E.2
Holton, J.L.3
Soulet, D.4
Hagell, P.5
Lees, A.J.6
-
29
-
-
0029743481
-
Distribution volume ratios without blood sampling from graphical analysis of PET data
-
Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996; 16: 83440.
-
(1996)
J Cereb Blood Flow Metab
, vol.16
, pp. 83440
-
-
Logan, J.1
Fowler, J.S.2
Volkow, N.D.3
Wang, G.J.4
Ding, Y.S.5
Alexoff, D.L.6
-
30
-
-
33746924055
-
Non-linear random effects model for multivariate responses with missing data
-
Marshall G, Cruz-Mesia R, Baron AE, Rutledge JH, Zerbe GO. Non-linear random effects model for multivariate responses with missing data. Stat Med 2006; 25: 281730.
-
(2006)
Stat Med
, vol.25
, pp. 281730
-
-
Marshall, G.1
Cruz-Mesia, R.2
Baron, A.E.3
Rutledge, J.H.4
Zerbe, G.O.5
-
31
-
-
0024457531
-
Nigrostriatal function in humans studied with positron emission tomography
-
Martin WR, Palmer MR, Patlak CS, Calne DB. Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol 1989; 26: 53542.
-
(1989)
Ann Neurol
, vol.26
, pp. 53542
-
-
Martin, W.R.1
Palmer, M.R.2
Patlak, C.S.3
Calne, D.B.4
-
32
-
-
0023740773
-
Rate of cell death in parkinsonism indicates active neuropathological process
-
McGeer PL, Itagaki S, Akiyama H, McGeer EG. Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 1988; 24: 5746.
-
(1988)
Ann Neurol
, vol.24
, pp. 5746
-
-
McGeer, P.L.1
Itagaki, S.2
Akiyama, H.3
McGeer, E.G.4
-
33
-
-
0242384667
-
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration
-
McGeer PL, Schwab C, Parent A, Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine administration. Ann Neurol 2003; 54: 599604.
-
(2003)
Ann Neurol
, vol.54
, pp. 599604
-
-
McGeer, P.L.1
Schwab, C.2
Parent, A.3
Doudet, D.4
-
34
-
-
0029981856
-
An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease
-
Morrish PK, Sawle GV, Brooks DJ. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 1996; 119 (Pt 2): 58591.
-
(1996)
Brain
, vol.119
, Issue.PART 2
, pp. 58591
-
-
Morrish, P.K.1
Sawle, G.V.2
Brooks, D.J.3
-
35
-
-
0037014426
-
Protein misfolding, amyloid formation, and neurodegen-eration: A critical role for molecular chaperones?
-
Muchowski PJ. Protein misfolding, amyloid formation, and neurodegen-eration: a critical role for molecular chaperones? Neuron 2002; 35: 912.
-
(2002)
Neuron
, vol.35
, pp. 912
-
-
Muchowski, P.J.1
-
36
-
-
0034718470
-
Progression of Hoehn and Yahr stages in Parkinsonian disorders: A clinicopathologic study
-
Muller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I. Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology 2000; 55: 88891.
-
(2000)
Neurology
, vol.55
, pp. 88891
-
-
Muller, J.1
Wenning, G.K.2
Jellinger, K.3
McKee, A.4
Poewe, W.5
Litvan, I.6
-
37
-
-
0022389649
-
Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations
-
Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985; 5: 58490.
-
(1985)
J Cereb Blood Flow Metab
, vol.5
, pp. 58490
-
-
Patlak, C.S.1
Blasberg, R.G.2
-
38
-
-
19944432710
-
The role of radiotracer imaging in Parkinson disease
-
Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, et al. The role of radiotracer imaging in Parkinson disease. Neurology 2005; 64: 20815.
-
(2005)
Neurology
, vol.64
, pp. 20815
-
-
Ravina, B.1
Eidelberg, D.2
Ahlskog, J.E.3
Albin, R.L.4
Brooks, D.J.5
Carbon, M.6
-
39
-
-
0031684326
-
Mitochondria in the etiology and pathogenesis of Parkinson's disease
-
Schapira AH, Gu M, Taanman JW, Tabrizi SJ, Seaton T, Cleeter M, et al. Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann Neurol 1998; 44: S8998.
-
(1998)
Ann Neurol
, vol.44
-
-
Schapira, A.H.1
Gu, M.2
Taanman, J.W.3
Tabrizi, S.J.4
Seaton, T.5
Cleeter, M.6
-
40
-
-
0028308151
-
A mathematical model of pathogenesis in idiopathic parkinsonism
-
Schulzer M, Lee CS, Mak EK, Vingerhoets FJ, Calne DB. A mathematical model of pathogenesis in idiopathic parkinsonism. Brain 1994; 117 (Pt 3): 50916.
-
(1994)
Brain
, vol.117
, Issue.PART 3
, pp. 50916
-
-
Schulzer, M.1
Lee, C.S.2
Mak, E.K.3
Vingerhoets, F.J.4
Calne, D.B.5
-
41
-
-
0037378897
-
Apoptosis in Parkinson's disease: Signals for neuronal degradation
-
Tatton WG, Chalmers-Redman R, Brown D, Tatton N. Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann Neurol 2003; 53 (Suppl 3): S6170.
-
(2003)
Ann Neurol
, vol.53
, Issue.SUPPL 3
-
-
Tatton, W.G.1
Chalmers-Redman, R.2
Brown, D.3
Tatton, N.4
|